The gene for spinocerebellar ataxia type 2 (SCA2) has been mapped to 12q24.1. A1.1–megabase
contig in the candidate region was assembled in P1 artificial chromosome and …

Neurofibromatosis type 2 (NF2) is a monogenic dominantly inherited disease predisposing
carriers to develop nervous system tumours. To identify the genetic defect, the region …

Potassium channel mutations have been described in episodic neurological diseases 1 . We
report that K + channel mutations cause disease phenotypes with neurodevelopmental and …

Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective
treatment. We report the results of a moderate-scale sequencing study aimed at increasing the …

Spinocerebellar ataxia type 10 (SCA10; MIM 603516; refs 1, 2) is an autosomal dominant
disorder characterized by cerebellar ataxia and seizures. The gene SCA10 maps to a 3.8-cM …

There are no disease-modifying treatments for adult human neurodegenerative diseases.
Here we test RNA-targeted therapies 1 in two mouse models of spinocerebellar ataxia type 2 (…

Genetic linkage analysis is a powerful tool to detect the chromosomal location of disease
genes. It is based on the observation that genes that reside physically close on a chromosome …

Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disease that
is characterized by motor neuron loss and that leads to paralysis and death 2–5 years after …

Nine neurodegenerative diseases, collectively referred to as polyglutamine (polyQ) diseases,
are caused by expansion of a coding CAG DNA trinucleotide repeat. PolyQ diseases show …

Instability of CAG DNA trinucleotide repeats is the mutational mechanism for several
neurodegenerative diseases resulting in the expansion of a polyglutamine (polyQ) tract. Proteins …